Swissmedic Grants Initial Authorization for Wainzua®: Key Regulatory Update
Swissmedic, the Swiss agency responsible for licensing and monitoring therapeutic products, has announced the initial authorization for Wainzua®. This development…
Switzerland
Switzerland updates on medical device regulation and quality.
156 articles
156 articles in Switzerland
Europe
Europe
Tamsulosin and Its Association with Intraoperative Floppy Iris Syndrome: Swissmedic Insights
Swissmedic has issued an important notice about the risks of intraoperative floppy iris syndrome (IFIS) among patients undergoing cataract surgery…
Europe
Swissmedic Updates on Veterinary Drug Reactions: Key Insights from 2024 Reports
The latest vigilance report from Swissmedic highlights significant findings regarding adverse reactions to veterinary medicinal products reported in Switzerland during…
Europe
Swissmedic Advisory: Reduced Shelf Life for Lecigon (Carbidopa/Entacapone/Levodopa)
Swissmedic has issued a health professional communication regarding a change in the shelf life of Lecigon, a medication containing carbidopa,…
Europe
Swissmedic Approves Initial Authorization for Sogroya®: Key Details for Regulatory Professionals
Swissmedic has announced the first authorization for Sogroya®, marking a significant regulatory development. The approval introduces a new option within…
Europe
Swissmedic Update: Revised EU Medical Device Regulations Explained
On October 21, 2025, Swissmedic announced updates to key sections related to EU legal acts for medical devices. These revisions…
Europe
Temporary Authorization Issued for Seroquel XR 50 mg Tablets in Italian Packaging
On October 20, 2025, Swissmedic announced a temporary resolution to the supply shortage of Seroquel XR 50 mg retard tablets…
Europe
Swissmedic Grants Initial Approval for Imcivree®: What You Need to Know
Swissmedic has officially granted the initial authorisation for Imcivree®. This significant regulatory decision is vital for stakeholders in the clinical,…
Europe
Swissmedic Announces Limited Distribution Approval for Opdivo 40 mg/4 ml Infusion Concentrate Amid Supply Challenges
Swissmedic has issued a temporary authorization permitting the distribution of Opdivo 40 mg/4 ml Konzentrat zur Herstellung einer Infusionslösung in…
Europe
Urgent Recall of Similasan Schnupfen Globuli Batch 17900 Announced by Swissmedic
On October 16, 2025, Swissmedic issued an urgent announcement regarding the recall of batch 17900 of Similasan Schnupfen Globuli (15g),…
Europe
Urgent Recall Issued for Nobivac DHPPi Veterinary Injection for Dogs
On October 15, 2025, Swissmedic announced a batch recall of the veterinary medicine Nobivac DHPPi, a lyophilisate designed for the…
Europe
Swissmedic Highlights Regulatory Focus on Parenteral Cosmetic Products
Swissmedic has released key insights on parenteral products in the cosmetic sector. This update, published on October 13, 2025, emphasizes…
Loading more articles…